ANZ News
Also, a startup from Melbourne has raised $1 million in pre-seed funding for its chemotherapy dosing AI.
Also, a startup from Melbourne has raised $1 million in pre-seed funding for its chemotherapy dosing AI.
Also, a new AI-driven genomics platform developed in Queensland can identify cancer biomarkers and predict tumour responses to chemotherapy.
About 300 million prescription records were used to train the AI to reveal drug safety issues and opportunities for repurposing medicines.
Developed with Murdoch Children's Research Institute, the AI has shown 90% detection accuracy.
Developed at the University of South Australia, it could help doctors safely deprescribe obsolete medications.
Australian researchers look at the possibility of integrating cardiovascular risk screening with routine breast screening by using AI and mammograms.
The AI-powered app has been tested in over 20 global studies involving 10,000 families.
Also, a project developing AI for early periodontal disease detection has received over $1 million in grant funding from the Australian government.
The AI, integrated into a hand-held point-of-care device, demonstrated 94% diagnostic accuracy.